Delivery Order SPE2DB20D2014-SPE2DB25FC79B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml units, with a contract ceiling value of $2,224.32. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ML quantities, with a ceiling value of $7,944.73 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 22, 2025. The award was issued to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dorzolamide-Timolol eye drops (10ml) with a contract ceiling value of $1,318.75. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $13,261.23 delivery order to AmerisourceBergen Drug Corp for dorzolamide-timolol eye drops (10mL) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,110.96 delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating the award was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $1,046.40 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,415,169 units of Dorzolamide HCl 2% eye drops in 10 mL bottles. The order has an ultimate completion date of August 12, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to...
- The Defense Logistics Agency awarded a $3,495.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10mL units, with an ultimate completion date of September 15, 2025. This non-set-aside contract was competitively awarded on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order issued under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,594.95 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol Eye Drops (10ml) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,205.62, is for the delivery of 4566405243 - Dorzolamide HCL 2% Eye Drops 10ML. This is a Firm Fixed Price Delivery Order contract with a completion date of November 13, 2024. The award is not associated with a set-aside program. In addition to this specific delivery order, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,258.38 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC79BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dorzolamide HCL 2% eye drops in 10ml quantities, with a contract ceiling value of $1,342.34. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/20/25 |